Molina Healthcare (NYSE:MOH – Get Free Report) announced its earnings results on Thursday. The company reported ($2.75) earnings per share for the quarter, missing the consensus estimate of $0.43 by ($3.18), FiscalAI reports. The business had revenue of $11.38 billion for the quarter, compared to the consensus estimate of $10.90 billion. Molina Healthcare had a net margin of 1.98% and a return on equity of 22.95%. Molina Healthcare updated its FY 2026 guidance to 5.000- EPS.
Molina Healthcare Trading Down 0.8%
Shares of NYSE:MOH traded down $1.35 during mid-day trading on Thursday, reaching $176.69. The stock had a trading volume of 2,192,747 shares, compared to its average volume of 1,400,202. The firm has a 50 day simple moving average of $172.98 and a two-hundred day simple moving average of $171.17. The firm has a market cap of $9.58 billion, a PE ratio of 10.94 and a beta of 0.49. Molina Healthcare has a twelve month low of $133.40 and a twelve month high of $359.97. The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.92.
Insider Buying and Selling
In related news, Director Richard M. Schapiro sold 357 shares of the firm’s stock in a transaction on Monday, November 24th. The shares were sold at an average price of $143.02, for a total transaction of $51,058.14. Following the sale, the director directly owned 11,352 shares in the company, valued at $1,623,563.04. This trade represents a 3.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 1.10% of the company’s stock.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
A number of brokerages recently weighed in on MOH. Weiss Ratings reissued a “sell (d+)” rating on shares of Molina Healthcare in a research note on Thursday, January 22nd. Sanford C. Bernstein reissued an “outperform” rating and issued a $224.00 price target on shares of Molina Healthcare in a research report on Tuesday, January 6th. Deutsche Bank Aktiengesellschaft set a $165.00 price target on Molina Healthcare in a report on Friday, October 24th. TD Cowen cut shares of Molina Healthcare from a “buy” rating to a “hold” rating and set a $203.00 target price for the company. in a research note on Thursday, October 16th. Finally, Truist Financial set a $175.00 price target on shares of Molina Healthcare in a research note on Friday, October 24th. Three investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $193.47.
Get Our Latest Analysis on MOH
Molina Healthcare Company Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Featured Articles
- Five stocks we like better than Molina Healthcare
- The day the gold market broke
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Your Bank Account Is No Longer Safe
- What a Former CIA Agent Knows About the Coming Collapse
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
